Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Hymenoptera venom allergy

Summer, sun, insect bite

    • Allergology and clinical immunology
    • Congress Reports
    • Emergency and intensive care medicine
    • General Internal Medicine
    • RX
  • 3 minute read

Hymenoptera venom allergy – commonly called insect venom allergy – is one of the so-called “Big 3” of severe allergic reactions, along with food and drug allergies. No one is immune: the risk of anaphylactic reaction after a bee or wasp sting is estimated at about 5%, and the recurrence rate is not insignificant. Anyone who has had a systemic reaction should therefore always have an emergency kit at hand.

The next summer is sure to come – and with it the Hymenoptera. In our latitudes, stings from bees and wasps are relatively common. In Switzerland, nine different species of wasps are known (out of a total of around 60) that sting and can cause allergic reactions. However, bumblebees and ants can also cause allergies, although this happens rather rarely (Tab. 1) . Ants are counted among the hymenoptera because they have wings before they build their nests. These are not shed until the nest is built.

Hymenoptera venom allergies are classified as accidents. According to the Swiss accident insurance company Suva, more than 10,000 such accidents due to hymenopteran stings occur every year, causing annual costs of about 20 million CHF (the average cost per accident is estimated at about 750 CHF). Regardless of whether it is a bee or wasp sting, about one in ten stings triggers an allergy. About 40 stings per year result in reactions so severe that work absences of >3 months occur. “These severe cases may be accompanied by paralysis, cerebral stroke or myocardial infarction, which not only has serious consequences for the affected person, but is also statistically significant with high costs,” explained Prof. Dr. Arthur Helbling, University Department of Pneumology and Allergology at the Inselspital Bern [1]. In such cases, the clarification is rarely carried out via the accident insurance, but as a rule via the health insurance.

Evaluate severe reactions allergologically

Any severe reaction such as airway obstruction, dyspnea, or circulatory involvement should be evaluated by an allergist for allergen-specific immunotherapy (VIT). If, on the other hand, a patient reacts only locally, e.g. by swelling after a prick in the tongue, this is unpleasant for the person concerned, but does not need to be clarified, as it does not entail any therapeutic consequences. In such cases, he said, prophylaxis rather than diagnosis or treatment should be considered.

For individuals who have exhibited systemic allergic reactions (SAR) – whether involving the skin, gastrointestinal tract, respiratory system, or circulatory system – Prof. Helbling strongly advises carrying kits of emergency medications. This would include an epinephrine auto-injector. “Even mild systemic reactions such as urticaria are associated with a fourfold increased risk of recurrence. If a shock reaction has been suffered, the risk of recurrence with a next sting is 50-70%. From these numbers alone, you can already see the point of VIT.” Treatment with bee or wasp venom lasts at least 5 years. Successful VIT reduces the risk of relapse, but the effect does not last a lifetime. It is believed that the risk after aborting a VIT is about 10% per stitch.

Take-Home Messages

  • Insect venom allergy is a common cause of anaphylaxis – and it
    can affect anyone.
  • Any more severe reaction should be allergologically evaluated for VIT.
    Evaluate.
  • After anaphylaxis, equip each patient with emergency medication/epinephrine auto-injector.
  • Even after completion of successful VIT for 5 years, relapse of SAR is possible.

Source: 1st FomF – WebUp 6 highlights in 60 minutes “Update Allergology”, lecture “Hymenoptera venom allergies”, 12.12.2022.

InFo PNEUMOLOGY & ALLERGOLOGY 2023; 5(1): 23 (published 2/23/22, ahead of print)

Autoren
  • Jens Dehn
Publikation
  • InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
  • Allergen specific immunotherapy
  • Allergic reaction
  • Emergency kit
  • Hymenoptera venom allergy
  • Insect venom allergy
  • VIT
Previous Article
  • Alopecia areata: drug therapy

Which method achieves the best hair growth rates?

  • Allergology and clinical immunology
  • Congress Reports
  • Dermatology and venereology
  • Infectiology
  • RX
  • Studies
  • Unkategorisiert
View Post
Next Article
  • Growth hormone deficiency in childhood and adolescence

Current treatment options – an update

  • Education
  • Endocrinology and Diabetology
  • General Internal Medicine
  • Pediatrics
  • RX
  • Studies
  • Unkategorisiert
View Post
You May Also Like
View Post
  • 12 min
  • Evidence, effectiveness and practical implications

Medicinal plants for allergic rhinitis

    • RX
    • Allergology and clinical immunology
    • Education
    • General Internal Medicine
    • ORL
    • Pharmaceutical medicine
    • Phytotherapy
    • Studies
View Post
  • 15 min
  • Current status and future prospects

Cell and gene therapies in modern cardiology

    • Cardiology
    • Education
    • Genetics
    • RX
    • Studies
View Post
  • 14 min
  • Patient-oriented recommendations for action

Effect of heat on diabetes technology

    • RX
    • CME continuing education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Prevention and health care
    • Studies
View Post
  • 19 min
  • Cardiovascular risk and obesity

Pathomechanisms, secondary prevention and treatment options

    • RX
    • Cardiology
    • CME continuing education
    • Endocrinology and Diabetology
    • Nutrition
    • Sports Medicine
    • Studies
    • Training with partner
View Post
  • 6 min
  • Ventricular arrhythmias

Indication for ICD or WCD?

    • RX
    • Cardiology
    • Congress Reports
    • General Internal Medicine
    • Studies
View Post
  • 3 min
  • Early breast cancer

Overweight and obesity worsen the prognosis

    • Congress Reports
    • Gynecology
    • Oncology
    • Prevention and health care
    • RX
    • Studies
View Post
  • 8 min
  • Psoriasis treatment with biologics

What are the latest trends?

    • Congress Reports
    • Dermatology and venereology
    • Pharmacology and toxicology
    • Rheumatology
    • RX
    • Studies
View Post
  • 4 min
  • Flu vaccination for older people

Benefit of the high-dose influenza vaccine

    • Congress Reports
    • General Internal Medicine
    • Geriatrics
    • Infectiology
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Pathomechanisms, secondary prevention and treatment options
  • 2
    Effect of heat on diabetes technology
  • 3
    Improved quality of care aims for satisfied patients
  • 4
    Dr. ChatGPT: Large language models in everyday clinical practice
  • 5
    Examinations and considerations before therapy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.